Company filings profile · CIK 0001778922

SpyGlass Pharma, Inc. — SEC filings & insider activity.

Real, source-linked SEC EDGAR activity for SpyGlass Pharma, Inc. (SGP): 3 filings in the last 90 days vs 2 in the prior 90 (filing-velocity rising ↑ · 1.5×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.

✔ Verified against the public SEC EDGAR filing record as of Oct 2, 2026. Source-linked, daily-refreshed.

Material 8-K events — SpyGlass Pharma, Inc.

8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).

FiledEvent
Oct 1, 2026Regulation FD Disclosure; Other Events; Financial Statements and Exhibits↗
Aug 6, 2026Results of Operations (earnings); Financial Statements and Exhibits↗
May 14, 2026Results of Operations (earnings); Financial Statements and Exhibits↗
Mar 26, 2026Results of Operations (earnings); Financial Statements and Exhibits↗
Mar 9, 2026Other Events; Financial Statements and Exhibits↗
Feb 13, 2026Departure/Election of Directors or Officers↗

Watch SpyGlass Pharma, Inc. automatically

Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.

Insider transactions (Form 4 / 3 / 5)

FiledForm
Feb 11, 20264↗
Feb 11, 20264↗
Feb 11, 20264↗
Feb 11, 20264↗
Feb 11, 20264↗
Feb 11, 20264↗
Feb 11, 20264↗
Feb 11, 20264↗
Feb 11, 20264↗
Feb 11, 20264↗
Feb 11, 20264↗
Feb 11, 20264↗
Feb 11, 20264↗
Feb 10, 20264↗
Feb 10, 20264↗
Feb 9, 20264↗
Feb 9, 20264↗
Feb 9, 20264↗
Feb 9, 20264↗
Feb 9, 20264↗

Recent filings

FiledFormDetail
Oct 1, 20268-K Regulation FD Disclosure; Other Events; Financial Statements and Exhibits ↗
Aug 6, 202610-Q 10-Q ↗
Aug 6, 20268-K Results of Operations (earnings); Financial Statements and Exhibits ↗
May 14, 202610-Q 10-Q ↗
May 14, 20268-K Results of Operations (earnings); Financial Statements and Exhibits ↗
Mar 26, 202610-K 10-K ↗
Mar 26, 20268-K Results of Operations (earnings); Financial Statements and Exhibits ↗
Mar 9, 20268-K Other Events; Financial Statements and Exhibits ↗
Feb 17, 2026SCHEDULE 13G ↗
Feb 17, 2026SCHEDULE 13D ↗
Feb 13, 2026SCHEDULE 13D ↗
Feb 13, 2026SCHEDULE 13D ↗
Feb 13, 20268-K Departure/Election of Directors or Officers ↗
Feb 13, 2026SCHEDULE 13G ↗
Feb 11, 20264 ↗
Feb 11, 20264/A 4/A ↗
Feb 11, 20264 4 ↗
Feb 11, 20264 4 ↗
Feb 11, 20264 4 ↗
Feb 11, 20264 4 ↗
Feb 11, 20264 4 ↗
Feb 11, 20264 4 ↗
Feb 11, 20264 4 ↗
Feb 11, 20264 4 ↗
Feb 11, 20264 4 ↗
Feb 11, 20264 4 ↗
Feb 11, 20264 ↗
Feb 11, 20264 ↗
Feb 10, 2026SCHEDULE 13D ↗
Feb 10, 20264 4 ↗
Feb 10, 20264 4 ↗
Feb 9, 20264 ↗
Feb 9, 20264 4 ↗
Feb 9, 20264 ↗
Feb 9, 20264 ↗
Feb 9, 20264 ↗
Feb 9, 20264 ↗
Feb 9, 20264 ↗
Feb 9, 20264 ↗
Feb 9, 20264 ↗